Výsledky vyhľadávania - "Antidepressive Agents economics"

Impact of Depression on Work Productivity and Its Improvement after Outpatient Treatment with Antidepressants

Autori: Byong Joo Ham Jong Min Woo Se Joo Kim a ďalší

Prispievatelia: Byong Joo Ham Jong Min Woo Se Joo Kim a ďalší

Zdroj: Value in Health. 14:475-482

Predmety: Adult, Male, productivity, Antidepressive Agents/economics, Efficiency, Ambulatory Care*/economics, Young Adult, 03 medical and health sciences, 0302 clinical medicine, cost, Absenteeism, Ambulatory Care, Humans, presenteeism, Depressive Disorder, lost productive time, Health Policy, Depressive Disorder/drug therapy, Public Health, Environmental and Occupational Health, Depressive Disorder/economics, Middle Aged, Antidepressive Agents, 3. Good health, Antidepressive Agents/therapeutic use, Treatment Outcome, Ambulatory Care*/methods, depression, 8. Economic growth, Female, Depressive Disorder/psychology

Popis súboru: 475~482

Prístupová URL adresa: http://www.valueinhealthjournal.com/article/S1098301510000410/pdf
https://pubmed.ncbi.nlm.nih.gov/21669372
https://www.valueinhealthjournal.com/article/S1098301510000410/pdf
https://www.ncbi.nlm.nih.gov/pubmed/21669372
http://www.sciencedirect.com/science/article/pii/S1098301510000410
https://ir.ymlib.yonsei.ac.kr/handle/22282913/93897;
https://koreauniv.pure.elsevier.com/en/publications/impact-of-depression-on-work-productivity-and-its-improvement-aft
https://jhu.pure.elsevier.com/en/publications/impact-of-depression-on-work-productivity-and-its-improvement-aft-3

Financement de la psychiatrie en France, la question des médicaments onéreux : exemple de l’Esketamine dans l’épisode dépressif caractérisé résistant

Autori: Taillefer de Laportalière, Tanguy Jullien, Adeline Eyvrard, Frédéric a ďalší

Prispievatelia: Taillefer de Laportalière, Tanguy Jullien, Adeline Eyvrard, Frédéric a ďalší

Zdroj: ISSN: 0013-7006 ; L'Encéphale ; https://hal.science/hal-04490736 ; L'Encéphale, 2023, ⟨10.1016/j.encep.2023.09.007⟩.

Predmety: Étude de coût, Psychiatry, Psychiatrie, Esketamine, Cost-effectiveness analysis, MESH: Adult, MESH: Antidepressive Agents / economics, MESH: Excitatory Amino Acid Antagonists / economics, MESH: Excitatory Amino Acid Antagonists / therapeutic use, MESH: Female, MESH: France, MESH: Humans, MESH: Ketamine* / economics, MESH: Ketamine* / therapeutic use, MESH: Male, MESH: Middle Aged, MESH: Psychiatry / economics, MESH: Antidepressive Agents / therapeutic use, MESH: Depressive Disorder, Major / drug therapy, Major / economics, Major / psychology, Treatment-Resistant* / drug therapy, Treatment-Resistant* / economics, Treatment-Resistant* / psychology, MESH: Drug Costs / statistics & numerical data, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

Relation: info:eu-repo/semantics/altIdentifier/pmid/38040510; PUBMED: 38040510

Dostupnosť: https://hal.science/hal-04490736
https://doi.org/10.1016/j.encep.2023.09.007

Estimating the Danish Populations' Preferences for Pharmacogenetic Testing Using a Discrete Choice Experiment. The Case of Treating Depression: The case of depression

Autori: Herbild, Louise Bech, Mickael Gyrd-Hansen, Dorte

Zdroj: Bech, M, Gyrd-Hansen, D & Herbild, L 2009, ' Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment : The case of depression ', Value in Health, bind 12, nr. 4, s. 560-567. .

Predmety: Antidepressive Agents/economics, Pharmacogenetics/economics, Denmark, Decision Making, Statistics as Topic, Economic, Choice Behavior, Genetic Testing/economics, 03 medical and health sciences, 0302 clinical medicine, Depression/drug therapy, Models, Preferences, Surveys and Questionnaires, Patient Preference/economics, Humans, Genetic Testing, preferences, pharmacogenetics, Depression, Health Policy, discrete choice experiment, Public Health, Environmental and Occupational Health, Patient Preference, Antidepressive Agents, 3. Good health, Models, Economic, Discrete choice experiment, Pharmacogenetics, depression

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/18980634
http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2008.00465.x/references
https://www.sciencedirect.com/science/article/pii/S1098301510607991
https://www.ucviden.dk/da/publications/estimating-the-danish-populations-preferences-for-pharmacogenetic
https://www.ncbi.nlm.nih.gov/pubmed/18980634
https://www.ucviden.dk/da/publications/estimating-the-danish-populations-preferences-for-pharmacogenetic-2
https://core.ac.uk/display/82270642
https://portal.findresearcher.sdu.dk/da/publications/48123290-e0b8-11de-aefb-000ea68e967b

Depression and Sleep Disorders: Clinical Relevance, Economic Burden and Pharmacological Treatment

Autori: Fred W. Turek Paul Linkowski Julien Mendlewicz a ďalší

Zdroj: Neuropsychobiology. 42:107-119

Predmety: Depressive Disorder, Antidepressive Agents -- adverse effects, Depressive Disorder -- economics, Depressive Disorder -- drug therapy, Cost-Benefit Analysis, Sleep Initiation and Maintenance Disorders -- drug therapy, Antidepressive Agents -- therapeutic use, Sciences bio-médicales et agricoles, Sleep Initiation and Maintenance Disorders -- economics, Hypnotics and Sedatives -- economics, Antidepressive Agents, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Cost of Illness, Italy, Antidepressive Agents -- economics, Hypnotics and Sedatives -- therapeutic use, Sleep Initiation and Maintenance Disorders, Humans, Hypnotics and Sedatives, Sleep Stages, Hypnotics and Sedatives -- adverse effects, Sleep Stages -- drug effects

Popis súboru: No full-text files

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/11015028
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/54428/Details
https://pubmed.ncbi.nlm.nih.gov/11015028/
https://www.neuroscience.ox.ac.uk/publications/257528
https://www.ncbi.nlm.nih.gov/pubmed/11015028
https://www.scholars.northwestern.edu/en/publications/depression-and-sleep-disorders-clinical-relevance-economic-burden
https://www.karger.com/Article/Pdf/26680
https://hdl.handle.net/11380/310580
https://doi.org/10.1159/000026680

TLV exceeds its mandate in its drug survey / TLV överskrider sitt mandat i genomgång av läkemedel

Autori: Linnersten, L

Zdroj: Läkartidningen. 106(20):1407

Cheep not always the best / Billigt inte alltid bäst

Autori: Ajanki, T

Zdroj: Läkemedelsvärlden. 104(10):16

Antidepressive agents and cost-efficiency (letter) / Antidepressiva läkemedel och kostnadseffektivitet

Autori: Ruck, C

Zdroj: Läkartidningen. 97(23):2898

Change of medications according to new subsidizing regulations / Medicinskift efter nye tilskudsregler

Autori: Möller, Marianne Gaustad, Iselin Halvorsen Unkerskov, Janne a ďalší

Zdroj: Ugeskrift for Laeger. 174(12):820

Disease production as business idea / Sykdomsproduksjon som forretningside

Autori: Haug, C

Zdroj: Tidsskrift for Den Norske Laegeforening. 124(19):2469

Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment.

Autori: Brunello, Nicoletta Armitage, R Feinberg, I a ďalší

Zdroj: Neuropsychobiology, 42 (3

Predmety: Sciences bio-médicales et agricoles, Antidepressive Agents -- adverse effects, Antidepressive Agents -- economics, Antidepressive Agents -- therapeutic use, Cost of Illness, Cost-Benefit Analysis, Depressive Disorder -- drug therapy, Depressive Disorder -- economics, Humans, Hypnotics and Sedatives -- adverse effects, Hypnotics and Sedatives -- economics, Hypnotics and Sedatives -- therapeutic use, Italy, Sleep Initiation and Maintenance Disorders -- drug therapy, Sleep Initiation and Maintenance Disorders -- economics, Sleep Stages -- drug effects

Popis súboru: No full-text files

Relation: uri/info:pii/nps42107; uri/info:pmid/11015028

Dostupnosť: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/54428